Related Experiment Video
Updated: May 12, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11
Pincheng Zhou1, Fengze Sun2, Peixu Lin3
1School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, China.
Background:
The role of estrogen in liver cancer cells has attracted attention, but its specific actions and underlying mechanisms remain unclear.
Methods:
Flow CytoMetry and Western blotting were used to investigate the mechanism of HOXA11-AS and estrogen in promoting apoptosis of hepatocellular carcinoma (HCC). In vivo subcutaneous tumorigenesis assays were uesd to confirm the regulatory role of HOXA11-AS in HCC progression. Through immunohistochemistry, the correlation between HOXA11 expression and the prognosis of patients with HCC was explored.
Results:
Estrogen was found to promote apoptosis in HCC cells, dependent on HOXA11-AS. HOXA11 and HOXA11-AS are upregulated in HCC tissues. Downregulation of HOXA11-AS and HOXA11 significantly inhibited cell proliferation, migration, and invasion in HCC. HOXA11-AS forms an RNA duplex with HOXA11, preventing RNase degradation. In HCC patients, high HOXA11 expression was significantly associated with lower overall survival (OS) (p=0.001) and disease-free survival (DFS) (p=0.002). High HOXA11 expression was also significantly correlated with recurrence (p<0.001), major vascular invasion (p=0.002) and increased tumor volume (p=0.007). Estrogen activated the c-met/AKT/mTOR pathway in the HCC cell line.
Conclusion:
Estrogen and its related proteins have therapeutic effects in HCC and may be new potential therapeutic targets.
Insights
Estrogen promotes liver cancer cell death via HOXA11-AS, a key regulator in hepatocellular carcinoma (HCC). Targeting estrogen and HOXA11 may offer new therapeutic strategies for HCC patients.
Area of Science:
- Hepatobiliary Neoplasms
- Molecular Oncology
- Endocrinology
Background:
- The precise role and mechanisms of estrogen in liver cancer remain incompletely understood.
- Investigating estrogen's influence on hepatocellular carcinoma (HCC) is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the mechanism by which estrogen and HOXA11-AS regulate apoptosis in HCC.
- To determine the correlation between HOXA11 expression and patient prognosis in HCC.
Main Methods:
- Flow cytometry and Western blotting were employed to study HOXA11-AS and estrogen's role in HCC apoptosis.
- In vivo assays assessed HOXA11-AS's regulatory function in HCC progression.
- Immunohistochemistry analyzed the link between HOXA11 expression and HCC patient outcomes.
Main Results:
- Estrogen-induced apoptosis in HCC cells is dependent on HOXA11-AS.
- HOXA11 and HOXA11-AS are upregulated in HCC tissues and promote proliferation, migration, and invasion.
- High HOXA11 expression correlates with poorer overall survival, disease-free survival, recurrence, vascular invasion, and larger tumor volume in HCC patients.
- Estrogen activates the c-met/AKT/mTOR pathway in HCC cells.
Conclusions:
- Estrogen and associated proteins demonstrate therapeutic potential in HCC.
- HOXA11-AS and estrogen represent promising therapeutic targets for hepatocellular carcinoma.
More Related Videos
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...